Adrenal growth occurs in experimental diabetes, and evidence exists for increased adrenal function. The concentration of PPRibP has been examined in the rat adrenal gland at various times after induction of diabetes with STZ, in view of the key role it plays in the synthesis of Purs and Pyrs. The PPRibP level was exceptionally high in the adrenal gland and increased faster than the rate of growth during the initial rapid growth phase—the first 7 days after STZ was given; PPRibP synthetase showed a parallel increase. Formation of R5P via the oxidative and nonoxidative segments of the PPP also was measured. The oxidative enzymes, G-6-PD and 6-PGD, increased in parallel with growth during the early phase, but showed a more marked rise during the secondary, slower, growth phase seen 6 wk after STZ was given, when this may be associated with the known sustained rise in plasma corticosteroids. The nonoxidative enzymes of the PPP, an alternate route for the production of pPPRibp, showed smaller changes. The specifically high adrenal concentration of PPRibP may be related to the high Km for PPRibP (250 μM) of the first enzyme of the de novo pathway of Pur synthesis, as such synthesis may be required in the rat to replace the net loss of ATP associated with catecholamine secretion. Factors controlling PPRibP synthetase and their potential relative importance in the adrenal gland have been considered.
Phosphoribosyl Pyrophosphate Formation in the Rat Adrenal Gland in Relation to Adrenal Growth in Experimental Diabetes
Sirilaksana Kunjara, Milena Sochor, Salah Ahmed, A Leslie Greenbaum, Patricia McLean; Phosphoribosyl Pyrophosphate Formation in the Rat Adrenal Gland in Relation to Adrenal Growth in Experimental Diabetes. Diabetes 1 November 1992; 41 (11): 1429–1435. https://doi.org/10.2337/diab.41.11.1429
Download citation file: